(0.51%) 5 214.08 points
(0.85%) 39 388 points
(0.27%) 16 346 points
(0.53%) $79.68
(0.43%) $2.31
(0.59%) $2 354.10
(0.85%) $28.61
(0.27%) $993.50
(0.00%) $0.927
(-0.21%) $10.84
(-0.02%) $0.798
(0.00%) $92.55
4 days till quarter result
(bmo 2024-05-13)
Expected move: +/- 9.08%
Live Chart Being Loaded With Signals
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals...
Stats | |
---|---|
Šios dienos apimtis | 54 715.00 |
Vidutinė apimtis | 157 504 |
Rinkos kapitalizacija | 35.07M |
EPS | $0 ( 2024-03-27 ) |
Kita pelno data | ( $-0.210 ) 2024-05-13 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.940 |
ATR14 | $0.00900 (0.80%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-06-21 | Robertson Judith J. | Buy | 5 500 | Stock Option (right to buy) |
2023-06-21 | Maderis Gail J | Buy | 5 500 | Stock Option (right to buy) |
2023-06-21 | Garcia Peter S | Buy | 5 500 | Stock Option (right to buy) |
2023-06-21 | Farfel Gail M | Buy | 5 500 | Stock Option (right to buy) |
2023-06-21 | Blaschke Terrence F | Buy | 5 500 | Stock Option (right to buy) |
INSIDER POWER |
---|
99.11 |
Last 97 transactions |
Buy: 5 988 954 | Sell: 1 498 606 |
Tūris Koreliacija
DURECT Corp Koreliacija
10 Labiausiai teigiamai susiję koreliacijos | |
---|---|
APOP | 0.917 |
RMRM | 0.903 |
KNSL | 0.895 |
GAINL | 0.885 |
MRSN | 0.884 |
DDI | 0.882 |
EDRY | 0.881 |
TW | 0.878 |
KYMR | 0.877 |
KTRA | 0.87 |
10 Labiausiai neigiamai susiję koreliacijos | |
---|---|
BOCH | -0.926 |
SRNGW | -0.896 |
DSPC | -0.88 |
GSM | -0.878 |
MMAC | -0.878 |
SVOK | -0.873 |
RTPY | -0.863 |
RELL | -0.859 |
VIH | -0.859 |
TCFC | -0.858 |
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
DURECT Corp Koreliacija - Valiuta/Žaliavos
DURECT Corp Finansinės ataskaitos
Annual | 2023 |
Pajamos: | $8.55M |
Bruto pelnas: | $6.83M (79.91 %) |
EPS: | $-1.050 |
FY | 2023 |
Pajamos: | $8.55M |
Bruto pelnas: | $6.83M (79.91 %) |
EPS: | $-1.050 |
FY | 2022 |
Pajamos: | $19.28M |
Bruto pelnas: | $17.70M (91.76 %) |
EPS: | $-1.560 |
FY | 2021 |
Pajamos: | $13.98M |
Bruto pelnas: | $12.02M (86.01 %) |
EPS: | $-0.0161 |
Financial Reports:
No articles found.
DURECT Corp
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogenous, orally bioavailable small molecule that is in Phase IIb clinical trial to play a regulatory role in lipid metabolism, stress and inflammatory responses, and cell death and survival to treat alcohol-associated hepatitis, as well as completed Phase Ib clinical trial to treat patients with nonalcoholic steatohepatitis. In addition, the company offers POSIMIR, a post-surgical pain product to deliver bupivacaine up to days of in adults; and Methydur to treat attention deficit hyperactivity disorder. It markets and sells its ALZET lines through direct sales force in the United States, as well as through a network of distributors in Japan, Europe, and internationally. The company has strategic collaboration and other agreements with Virginia Commonwealth University Intellectual Property Foundation; Indivior UK Ltd.; and Santen Pharmaceutical Co., Ltd. DURECT Corporation was incorporated in 1998 and is headquartered in Cupertino, California.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.